Clarke, Geraldine M, Rockett, Kirk, Kivinen, Katja, Hubbart, Christina, Jeffreys, Anna E, Rowlands, Kate, Jallow, Muminatou, Conway, David J, Bojang, Kalifa A, Pinder, Margaret, Usen, Stanley, Sisay-Joof, Fatoumatta, Sirugo, Giorgio, Toure, Ousmane, Thera, Mahamadou A, Konate, Salimata, Sissoko, Sibiry, Niangaly, Amadou, Poudiougou, Belco, Mangano, Valentina D, Bougouma, Edith C, Sirima, Sodiomon B, Modiano, David, Amenga-Etego, Lucas N, Ghansah, Anita, Koram, Kwadwo A, Wilson, Michael D, Enimil, Anthony, Evans, Jennifer, Amodu, Olukemi K, Olaniyan, Subulade, Apinjoh, Tobias, Mugri, Regina, Ndi, Andre, Ndila, Carolyne M, Uyoga, Sophie, Macharia, Alexander, Peshu, Norbert, Williams, Thomas N, Manjurano, Alphaxard, Sepúlveda, Nuno, Clark, Taane G, Riley, Eleanor, Drakeley, Chris, Reyburn, Hugh, Nyirongo, Vysaul, Kachala, David, Molyneux, Malcolm E, Dunstan, Sarah J, Phu, Nguyen Hoan, Quyen, Nguyen Ngoc, Thai, Cao Quang, Hien, Tran Tinh, Manning, Laurens, Laman, Moses, Siba, Peter, Karunajeewa, Harin, Allen, Steve, Allen, Angela, Davis, Timothy Me, Michon, Pascal, Mueller, Ivo, Molloy, Síle F, Campino, Susana, Kerasidou, Angeliki, Cornelius, Victoria J, Hart, Lee, Shah, Shivang S, Band, Gavin, Spencer, Chris Ca, Agbenyega, Tsiri, Achidi, Eric, Doumbo, Ogobara K, Farrar, Jeremy, Marsh, Kevin, Taylor, Terrie and Kwiatkowski, Dominic P (2017) 'Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.'. eLife, Vol 6, e15085.
|
Text
elife_2017_6_e15085.pdf - Published Version Available under License Creative Commons Attribution. Download (3MB) | Preview |
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is believed to confer protection against Plasmodium falciparum malaria, but the precise nature of the protective effect has proved difficult to define as G6PD deficiency has multiple allelic variants with different effects in males and females, and it has heterogeneous effects on the clinical outcome of P. falciparum infection. Here we report an analysis of multiple allelic forms of G6PD deficiency in a large multi-centre case-control study of severe malaria, using the WHO classification of G6PD mutations to estimate each individual’s level of enzyme activity from their genotype. Aggregated across all genotypes, we find that increasing levels of G6PD deficiency are associated with decreasing risk of cerebral malaria, but with increased risk of severe malarial anaemia. Models of balancing selection based on these findings indicate that an evolutionary trade-off between different clinical outcomes of P. falciparum infection could have been a major cause of the high levels of G6PD polymorphism seen in human populations.
Item Type: | Article |
---|---|
Subjects: | QU Biochemistry > Enzymes > QU 135 Enzymes QU Biochemistry > Genetics > QU 460 Genomics. Proteomics WC Communicable Diseases > Tropical and Parasitic Diseases > WC 750 Malaria WC Communicable Diseases > Tropical and Parasitic Diseases > WC 755 Epidemiology |
Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department |
Digital Object Identifer (DOI): | https://doi.org/10.7554/elife.15085 |
SWORD Depositor: | JISC Pubrouter |
Depositing User: | JISC Pubrouter |
Date Deposited: | 23 Feb 2017 13:53 |
Last Modified: | 17 Aug 2022 08:57 |
URI: | https://archive.lstmed.ac.uk/id/eprint/6843 |
Statistics
Actions (login required)
Edit Item |